Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
Date:4/24/2008

SAN DIEGO, April 24 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has established a distribution partnership in the Czech market through the Almeda Company, a Prague-based firm specializing in medical device sales in the region for almost two decades.

Michel Vaudry, SpectraScience's Director of International Sales commented that "the Czech Republic is attractive on many fronts as an entry point into the European market for our WavSTAT System, both for its aging population and its established $1.2 billion medical device market. In addition, the Czech Republic has one of the highest incidences of colorectal cancer in the world. We are exploring additions to our export sales team in other European countries such as Italy, Germany and France."

Almeda's Director Ales Zavorka stated that "the WavSTAT System fills a significant gap in our product offering to the Czech market which has a particularly high incidence of colon cancer. Other drivers for the product in the market are its ease of use and performance, both of which are extremely appealing to the physician community."

Key Benefits to the WavSTAT Optical Biopsy System

-- Leaves polyps on site if they are not pre-cancerous

-- Ability for physician to perform physical biopsy at exactly same site

as optical biopsy

-- Aids physician during colon cancer surgery

-- Complementary to NBI and Smart Pill

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosu
'/>"/>

SOURCE SpectraScience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. SpectraScience, Inc. Retains Hayden Communications
2. SpectraScience Acquires Luma Imaging Corporation
3. SpectraScience Receives Final European Certification
4. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
5. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Piedmont Pharmaceuticals Secures $8.5 Million Investment
8. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
9. UI licensee Optherion secures $37 million in financing
10. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
11. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ICAGO, Dec. 3 Research ...evice and functional MRI (fMRI) have found that,c...ding to a study presented,today at the annual mee...,(RSNA). This is the first study using fMRI to map...n. , "We have shown that the brain has the ...
(Date:12/2/2008)...UISVILLE, Ky., Dec. 2 A...d meaningful images from the bits of information w... Grawemeyer Award for Psychology. , Anne Treism...y Professor,of psychology at Princeton Universit...ogy prize from among 28 nominations. , Trei...
(Date:12/2/2008)...A team of researchers from Monash University, The ...ical School and Vanda Pharmaceuticals has found a ...nd sleep disorders caused by shift work. , Dr S...of Psychology, Psychiatry and Psychological Medici...n receptors in the brain, could be a highly effect...
(Date:12/2/2008)...tients given Trasylol have a higher death risk, da...lthDay News) -- A new study casts more doubt on t...o limit bleeding in patients undergoing surgery. ,... in the United States, where it was removed from t... and Australian researchers reviewed findings from...
Breaking Medicine News(10 mins):Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2Health News:New medication brings hope of jet lag cure 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2
... have said in the British Medical Journal that the...tals since 1990, based on mythical safety risks, a...phones were banned in hospitals after fears of the...and to prevent the potential confusion between the...
...ar 500,000 Americans develop pneumococcal pneumoni... serious, possibly fatal, illness. The October iss...g the word: A vaccine is available that helps prot...pneumonia and reduces the serious complications of...
... with allergic symptoms like wheezing, asthma, ha...nsitization to their infants too, according to a s...ts that the current practice of avoiding skin test... 4 or 5 should be reconsidered, so children in thi...
... a clear indication in a scientific journal regard...ing clinical trial//, the drug was tested on human...re drug reaction. But for the timely emergency car...ve been history. A Dutch report documenting the ...
Other Medicine News:Health News:Allergy Sufferers Pass on Allergies to their Children 2
(Date:12/1/2008)...wire-USNewswire/ -- A study has found that positro...imaging the breast, is not affected by either brea...rs that limit the effectiveness of standard mammog... presented today at the annual meeting of the Radi..., "The ability of PEM to detect cancer does not ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... December 9 at 11:00 am ET to Discuss Phase 2 Stud...O, Calif., Dec. 1 Sune...pharmaceutical company focused on the development ..., today announced new data from its studies of vor...sented during the 50th American Society of Hematol...
(Date:11/28/2008)...swire/ -- German biotech company,Partec is expand...oring and,AIDS patient follow-up diagnostics for ...08, 2.5 million patient tests have been performed ...CyFlow" system, supporting already,more than 1 mi...tion of the,Partec innovation, the average cost o...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Medifast Adds New Crunchy Bars to Product Line 28861 1Medifast Adds New Crunchy Bars to Product Line 28861 2NCPA Statement on November 4th Election Results 28860 1NCPA Statement on November 4th Election Results 28860 2ConjuChem Provides Development Update 8911 1ConjuChem Provides Development Update 8911 2ConjuChem Provides Development Update 8911 3State fund advances titanium powder research 9 other Iowa State projects 5736 1State fund advances titanium powder research 9 other Iowa State projects 5736 2State fund advances titanium powder research 9 other Iowa State projects 5736 3State fund advances titanium powder research 9 other Iowa State projects 5736 4
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
MONOJECT Red/Yellow Mottled Stopper
BD Vacutainer® Specialty Tubes - Thrombin
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
Medicine Products: